E-LIB Suche - Ergebnisse für: Cao, Z Alexander

1

Association between gene expression signatures and clinical..:

Shitara, Kohei ; Di Bartolomeo, Maria ; Mandala, Mario...
Journal for ImmunoTherapy of Cancer. 11 (2023) 6 - p. e006920 , 2023

Link: https://doi.org/10.1136/..

2

Society for Immunotherapy of Cancer (SITC) consensus defini..:

Rizvi, Naiyer ; Ademuyiwa, Foluso O ; Cao, Z Alexander...
Journal for ImmunoTherapy of Cancer. 11 (2023) 3 - p. e005920 , 2023

Link: https://doi.org/10.1136/..

3

Evolution of predictive and prognostic biomarkers in the tr..:

Myer, Nicole M. ; Shitara, Kohei ; Chung, Hyun C....
Journal of Cancer Research and Clinical Oncology. 148 (2022) 8 - p. 2023-2043 , 2022

Link: https://doi.org/10.1007/..

4

Current strategies for intratumoural immunotherapy – Beyond..:

Yuan, Jianda ; Khilnani, Anuradha ; Brody, Joshua...
European Journal of Cancer. 157 (2021) - p. 493-510 , 2021

Link: https://doi.org/10.1016/..

5

RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signa..:

Nyfeler, Beat ; Chen, Yan ; Li, Xiaoyan...
PLoS ONE. 7 (2012) 11 - p. e48548 , 2012

Link: https://doi.org/10.1371/..

6

Transcriptomic Determinants of Response to Pembrolizumab Mo..:

Cristescu, Razvan ; Nebozhyn, Michael ; Zhang, Chunsheng...
Clinical Cancer Research. 28 (2021) 8 - p. 1680-1689 , 2021

Link: https://doi.org/10.1158/..

7

Society for Immunotherapy of Cancer (SITC) consensus defini..:

Rizvi, Naiyer ; Ademuyiwa, Foluso O ; Cao, Z Alexander...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016262/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Association between gene expression signatures and clinical..:

Shitara, Kohei ; Di Bartolomeo, Maria ; Mandala, Mario...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314681/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Transcriptomic Determinants of Response to Pembrolizumab Mo..:

Cristescu, Razvan ; Nebozhyn, Michael ; Zhang, Chunsheng...
qt4d58973z. , 2022

Link: https://escholarship.org..

10

Association of Tumor Mutational Burden with Efficacy of Pem..:

Lee, Keun-Wook ; Van Cutsem, Eric ; Bang, Yung-Jue...
Clinical Cancer Research, Vol.28 No.16, pp.3489-3498. , 2022

Link: https://hdl.handle.net/1..

11

Durable clinical benefit with nivolumab plus ipilimumab in ..:

Overman, Michael J ; Lonardi, Sara ; Wong, Ka Yeung Mark...
info:eu-repo/semantics/altIdentifier/pmid/29355075. , 2018

Link: http://hdl.handle.net/23..

12

Nivolumab in patients with metastatic DNA mismatch repair d..:

Overman, Michael J ; McDermott, Ray ; Leach, Joseph L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207072/. , 2017

Link: http://www.ncbi.nlm.nih...

13

CDK 4/6 inhibitors sensitize PIK3CA Mutant Breast Cancer to..:

Vora, Sadhna R ; Juric, Dejan ; Kim, Nayoon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155598/. , 2014

Link: http://www.ncbi.nlm.nih...

14

Society for Immunotherapy of Cancer (SITC) consensus defini..:

Ranee Mehra ; Ina Rhee ; Naiyer Rizvi...
https://jitc.bmj.com/content/11/3/e005920.full. , 2023

Link: https://doi.org/10.1136/..

15

Association between gene expression signatures and clinical..:

Kohei Shitara ; Kei Muro ; Razvan Cristescu...
https://jitc.bmj.com/content/11/6/e006920.full. , 2023

Link: https://doi.org/10.1136/..